Familial ALS: Genetic Testing and the Hope for Targeted Treatment

Mina Eroğlu, a 47-year-old archaeologist, has begun a targeted treatment protocol for Amyotrophic Lateral Sclerosis (ALS) after testing positive for a rare SOD1 gene mutation. According to Assoc. Prof. Dr. Hasan Armağan Uysal, early genetic mapping is critical for managing the disease, which often mimics other orthopedic issues during initial stages.

Eroğlu sought medical help last year after experiencing knee pain and walking difficulties. Tests revealed an ALS diagnosis, a condition that previously claimed the lives of two of her aunts and two cousins. Eroğlu stated that the disease’s history on her mother’s side was a decisive factor in the diagnostic process.

Genetic testing confirmed Eroğlu carries the SOD1 gene mutation, which she inherited from her mother. While her mother is a carrier and shows no symptoms, Eroğlu developed the disease. She noted that previous family members with ALS survived only three to five years after diagnosis.

How does the SOD1 mutation change treatment?

Because Eroğlu carries a rare SOD1 mutation, her medical team implemented a targeted treatment protocol. Eroğlu reported that this specific approach led to positive developments in her laboratory parameters and a reduction in muscle twitching.

She emphasized that early genetic mapping is critical for this process. According to Eroğlu, the success of such treatment requires high awareness and full coordination with the treating physician.

What are the symptoms and challenges of ALS?

ALS can begin in either the upper or lower body. In Eroğlu’s family, the disease manifests in the legs. She described her initial walking pattern as appearing “drunk” to outside observers.

Over time, Eroğlu experienced weakness in her abdominal and hand muscles, making it difficult to hold objects or stand up. She now uses a wheelchair in some situations due to leg muscle atrophy.

Eroğlu described the progression of the disease as feeling “trapped inside your own body.” She explained that as the illness advances, the weakening of facial and chest muscles can impair vital functions like chewing and breathing.

Why is ALS often misdiagnosed?

Assoc. Prof. Dr. Hasan Armağan Uysal stated that early ALS is frequently confused with nerve compression or herniated discs. He clarified that while muscle twitching is common in the general population, it only becomes a primary concern when accompanied by progressive power loss.

Dr. Uysal explained that there is currently no single blood test or imaging method that provides a definitive ALS diagnosis. Instead, doctors must rely on a combination of patient history, neurological examinations, EMG studies, and the exclusion of other possibilities.

What may happen next for patients with genetic ALS?

Medical research into genetic subgroups may offer further hope for patients. Dr. Uysal indicated that current studies focusing on these subgroups are promising, though he stressed that early diagnosis remains the most critical factor for every patient.

For patients like Eroğlu, maintaining mental activity could be a key part of their daily routine. Eroğlu, who now works as a freelance news editor and translator, stated that birdwatching and journaling help her maintain a sense of serenity.

Frequently Asked Questions

What is the SOD1 gene mutation?
It is a rare genetic mutation found in a small percentage of ALS patients that allows for the planning of targeted treatment protocols, according to Mina Eroğlu.

How is ALS diagnosed if there is no single test?
According to Assoc. Prof. Dr. Hasan Armağan Uysal, diagnosis is reached through patient history, neurological exams, EMG scans, and the exclusion of other potential conditions.

What are the most common misdiagnoses for ALS?
Dr. Uysal noted that ALS is frequently mistaken for herniated discs or nerve compression in its early stages.

Do you believe earlier genetic screening should be standard for families with a history of neurological disease?